Aclid
Latest round
- Seed
Last raised
- Jun 2023
Total raised
- $3.6M
Investors
- 2
About Aclid
, operates a biotechnology platform that provides various gene synthesis compliance solutions for customer verification, screening of DNA and RNA. Aclid offers a biosecurity platform used to provide threat assessments and risk profiles for extensive sequences of hundreds of thousands of base pairs to decrease risk factors and enhance biosecurity. The platform automates the verification of licenses, registrations, adherence to biosafety guidelines, and legitimate usage.
Who invested in Aclid
2 investors across 1 round
See all investors in Aclid
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jun 6, 2023
Amount
$3.6M
Investors
Questions about Aclid
Who invested in Aclid?
Aclid has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Aclid raised?
Aclid has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Aclid last raise money?
Aclid's most recent round on record is a Seed, in Jun 2023.
What does Aclid do?
, operates a biotechnology platform that provides various gene synthesis compliance solutions for customer verification, screening of DNA and RNA.
Where is Aclid headquartered?
Aclid is headquartered in New York, US.
Which VCs invest in companies like Aclid?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Aclid's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Aclid? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.